Treatment with Cardiostenol (commercial name of a pharmaceutical product containing morphine chloridrate+atropine+sparteine) does not modify the course of hepatitis in mice infected with MHV-3 virus. Similar results were previously obtained by treatment with morphine chloridrate alone.
[Effect of the administration of Cardiostenol on experimental hepatitis in mice induced with MHV-3 virus] / V., Guadagnino; Borgia, Guglielmo; A., Chirianni; Orlando, Raffaele; L., Picciotto; P. T., Cataldo; M., Piazza. - In: BOLLETTINO DELLA SOCIETA' ITALIANA DI BIOLOGIA SPERIMENTALE. - ISSN 0037-8771. - STAMPA. - 56:(1980), pp. 362-8.
[Effect of the administration of Cardiostenol on experimental hepatitis in mice induced with MHV-3 virus].
BORGIA, GUGLIELMO;ORLANDO, RAFFAELE;
1980
Abstract
Treatment with Cardiostenol (commercial name of a pharmaceutical product containing morphine chloridrate+atropine+sparteine) does not modify the course of hepatitis in mice infected with MHV-3 virus. Similar results were previously obtained by treatment with morphine chloridrate alone.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
